|
Total Revenue
|
|
$128.6m
|
$138.6m
|
$158.1m
|
$146.6m
|
$147.5m
|
$147.5m
|
$168.9m
|
$219.5m
|
$203.8m
|
$240.5m
|
|
Revenue, Net (Deprecated 2018-01-31)
|
|
$128.6m
|
$138.6m
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Cost of Revenue
|
|
$104.9m
|
$112.0m
|
$126.0m
|
$121.2m
|
$124.1m
|
$123.5m
|
$144.7m
|
$183.9m
|
$151.7m
|
$171.6m
|
|
Gross Profit
|
|
$23.7m
|
$26.6m
|
$32.0m
|
$25.3m
|
$23.4m
|
$24.0m
|
$24.2m
|
$35.6m
|
$52.1m
|
$68.9m
|
|
Operating Expenses
|
|
$18.0m
|
$20.1m
|
$22.9m
|
$23.2m
|
$25.8m
|
$25.3m
|
$26.8m
|
$30.2m
|
$33.8m
|
$51.1m
|
|
Operating Income (Loss)
|
|
$5.7m
|
$6.5m
|
$9.1m
|
$2.1m
|
($2.3m)
|
($1.3m)
|
($2.6m)
|
$5.4m
|
$18.3m
|
$17.8m
|
|
Additional Financial Items
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill, Impairment Loss
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$0
|
$0
|
|
Other Income
|
|
$347k
|
$496k
|
$693k
|
$389k
|
$426k
|
$241k
|
$400k
|
$939k
|
$814k
|
$240k
|
|
Income (Loss) from Continuing Operations before Income Taxes, Domestic
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$6.8m
|
|
Operating earnings
|
|
$6.5m
|
$9.1m
|
$2.1m
|
($2.3m)
|
($1.3m)
|
($2.6m)
|
$5.4m
|
$18.3m
|
$17.8m
|
$16.7m
|
|
Other income, net
|
|
$496k
|
$693k
|
$389k
|
$426k
|
$241k
|
$400k
|
$939k
|
$814k
|
$240k
|
$880k
|
|
Net earnings
|
|
$4.6m
|
$5.4m
|
$1.7m
|
($4.6m)
|
($3.6m)
|
($6.0m)
|
$1.4m
|
$19.1m
|
$11.6m
|
$10.5m
|
|
Less: net earnings attributable to the non-controlling interest
|
|
$105k
|
$177k
|
$159k
|
$63k
|
$65k
|
$123k
|
$621k
|
$304k
|
$178k
|
$847k
|
|
Net earnings attributable to Kewaunee Scientific Corporation
|
|
$4.5m
|
$5.2m
|
$1.5m
|
($4.7m)
|
($3.7m)
|
($6.1m)
|
$738k
|
$18.8m
|
$11.4m
|
$9.6m
|
|
Basic (in shares)
|
|
$2.7m
|
$2.7m
|
$2.7m
|
$2.8m
|
$2.8m
|
$2.8m
|
$2.8m
|
$2.9m
|
$2.9m
|
$2.9m
|
|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
|
|
$5.7m
|
$6.7m
|
$9.5m
|
$2.1m
|
($2.9m)
|
($2.6m)
|
($2.5m)
|
$4.5m
|
$13.1m
|
$14.8m
|
|
Net Income (Loss) Attributable to Parent
|
|
$3.8m
|
$4.5m
|
$5.2m
|
$1.5m
|
($4.7m)
|
($3.7m)
|
($6.1m)
|
$738k
|
$18.8m
|
$11.4m
|
|
Net Income (Loss) Attributable to Noncontrolling Interest
|
|
$75k
|
$105k
|
$177k
|
$159k
|
$63k
|
$65k
|
$123k
|
$621k
|
$304k
|
$178k
|
|
Earnings Per Share, Basic
|
|
$1.43
|
$1.67
|
$1.91
|
$0.56
|
($1.70)
|
($1.33)
|
($2.20)
|
$0.26
|
$6.51
|
$3.98
|
|
Earnings Per Share, Diluted
|
|
$1.42
|
$1.66
|
$1.87
|
$0.55
|
($1.70)
|
($1.33)
|
($2.20)
|
$0.25
|
$6.38
|
$3.83
|
|
Weighted Average Number of Shares Outstanding, Basic
|
|
2.7m
|
2.7m
|
2.7m
|
2.7m
|
2.8m
|
2.8m
|
2.8m
|
2.8m
|
2.9m
|
2.9m
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
|
2.7m
|
2.7m
|
2.8m
|
2.8m
|
2.8m
|
2.8m
|
2.8m
|
2.9m
|
2.9m
|
3.0m
|
|
Interest Expense (non-operating)
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$3.2m
|
$3.2m
|
|
Current Income Tax Expense (Benefit)
|
|
$2.2m
|
$2.5m
|
$3.4m
|
$419k
|
($673k)
|
$748k
|
$3.4m
|
$2.6m
|
$5.1m
|
$5.4m
|
|
Interest Expense
|
|
$306k
|
$292k
|
$299k
|
$367k
|
$493k
|
$389k
|
$632k
|
$1.7m
|
$1.8m
|
($3.9m)
|
|
Operating Lease, Expense
|
|
—
|
—
|
—
|
$2.4m
|
$2.4m
|
$2.9m
|
$3.1m
|
$3.3m
|
$3.5m
|
$4.4m
|
|
Research and Development Expense
|
|
$1.2m
|
$1.2m
|
$1.5m
|
$1.6m
|
$1.8m
|
$1.4m
|
$990k
|
$1.0m
|
$920k
|
$919k
|
|
Cost of products sold
|
|
$112.0m
|
$126.0m
|
$121.2m
|
$124.1m
|
$123.5m
|
$144.7m
|
$183.9m
|
$151.7m
|
$171.6m
|
$201.6m
|
|
Income tax expense
|
|
$2.1m
|
$4.1m
|
$446k
|
$1.8m
|
$990k
|
$3.5m
|
$3.1m
|
($5.9m)
|
$3.2m
|
$3.3m
|
|
Income Tax Expense (Benefit)
|
|
$1.9m
|
$2.1m
|
$4.1m
|
$446k
|
$1.8m
|
$990k
|
$3.5m
|
$3.1m
|
($5.9m)
|
$3.2m
|
|
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
($4.0m)
|
($4.0m)
|
—
|
|
Total earnings before income tax expense
|
|
$6.7m
|
$9.5m
|
$2.1m
|
($2.9m)
|
($2.6m)
|
($2.5m)
|
$4.5m
|
$13.1m
|
$14.8m
|
$13.7m
|